Key result
Placement of a unidirectional valve in an in vitro Fontan circulation model reduced upstream hepatic venous pressure by 5 to 10 mmHg and lowered energy loss to 20-50% of baseline.
Why the study?
Does placement of a unidirectional valve within the inferior vena cava improve hemodynamics in an in vitro model of Fontan circulation?
Does placement of a unidirectional valve within the inferior vena cava improve hemodynamics in an in vitro model of Fontan circulation?
In an in vitro model of Fontan circulation, implanting a unidirectional valve in the IVC reduced hepatic venous pressure and energy loss, suggesting a potential strategy to mitigate long-term complications like liver congestion.
May mitigate hepatic congestion in Fontan; leaves open translation from in vitro models to clinical outcomes.
The Fontan surgical procedure used for treating patients with single ventricle congenital heart disorders results in a total cavopulmonary connection (TCPC) of the vena cavae to the pulmonary arteries (PAs). Sluggish TCPC flow and elevated hepatic venous pressures are commonly observed in this altered physiology, which in turn can lead to long-term complications including liver congestion and cirrhosis. The hypothesis of this study is that placement of a unidirectional valve within the inferior vena cava (IVC) will improve hemodynamics of the Fontan circulation by preventing retrograde flow and lowering hepatic venous pressure. An in vitro experimental setup consisting of an idealized TCPC model with flexible walls was used for investigation, and a bovine venous valve was inserted in the IVC below the TCPC. Pressure fluctuations were introduced in the flow through the model to simulate venous pulsatility. Hemodynamics of baseline and valve-implanted conditions were compared across total caval flows ranging from 1.0 to 2.5 l/min with varying caval flow distributions. The results indicated that valve closure occurred for 15-20% of the total cycle, with consequent reduction in the upstream hepatic venous pressure by 5 to 10 mmHg. Energy loss (EL) through the TCPC was lowered with valve implantation to 20-50% of baseline, occurring across all flow conditions considered with mean caval and PA pressures greater than 10 mmHg. The results of this in vitro modeling suggest that IVC valve placement has the potential to improve hemodynamics in the Fontan circulation by decreasing hepatic venous hypertension and EL.
No takes yet. Share an insight, caveat, or question.
Santhanakrishnan et al. (2013) studied Fontan circulation / single ventricle congenital heart disorders. Placement of a unidirectional bovine venous valve within the inferior vena cava vs. Baseline conditions (without valve) was evaluated on Hemodynamics (hepatic venous pressure and energy loss). Placement of a unidirectional valve in an in vitro Fontan circulation model reduced upstream hepatic venous pressure by 5 to 10 mmHg and lowered energy loss to 20-50% of baseline.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: